Sentara Brings 1st Minimally Invasive Treatment for Aortic Regurgitation to Virginia - Poll - MDSpire

Sentara Brings 1st Minimally Invasive Treatment for Aortic Regurgitation to Virginia

For decades, open-heart surgery was the only treatment option for people with severe aortic valve disease. Patients too sick to withstand major surgery often faced a steady decline in heart function.

  • By

  • July 10, 2026

  • 4 min

Share

Original Source(s)

Sentara Brings 1st Minimally Invasive Treatment for Aortic Regurgitation to Virginia

  • by

  • July 10, 2026

Related Content

Bivalirudin as rescue therapy for suspected heparin resistance and recurrent intra-procedural stent thrombosis during complex percutaneous coronary intervention: a case report

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Investigating the association between low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and the risk of carotid artery plaque in patients with first-ever ischemic stroke based on different glucose metabolic conditions